122 related articles for article (PubMed ID: 4199824)
1. [Clinical and serological studies on a further attenuated live measles virus AIK vaccine].
Nino K
Kansenshogaku Zasshi; 1973 Apr; 47(4):116-24. PubMed ID: 4199824
[No Abstract] [Full Text] [Related]
2. Evaluation of the live AIK measles virus vaccine.
Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
Kitasato Arch Exp Med; 1973 Dec; 46(3-4):83-92. PubMed ID: 4805362
[No Abstract] [Full Text] [Related]
3. Measles vaccines used in Japan.
Hirayama M
Rev Infect Dis; 1983; 5(3):495-503. PubMed ID: 6879005
[TBL] [Abstract][Full Text] [Related]
4. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
[No Abstract] [Full Text] [Related]
5. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
[No Abstract] [Full Text] [Related]
6. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
[No Abstract] [Full Text] [Related]
7. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
[No Abstract] [Full Text] [Related]
8. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
[No Abstract] [Full Text] [Related]
9. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.
Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304
[TBL] [Abstract][Full Text] [Related]
10. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
KIMURA M; ISHIGURO Y
Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
[No Abstract] [Full Text] [Related]
11. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
Fulginiti VA; Helfer RE
JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
[TBL] [Abstract][Full Text] [Related]
12. [Clinical reactions and antibody responses of measles-susceptible healthy children to the live measles "AIK-C" vaccine(chick embryo tissue culture type)].
Okayama T
Kansenshogaku Zasshi; 1975 Apr; 49(4):150-8. PubMed ID: 811729
[No Abstract] [Full Text] [Related]
13. Experiences in mass prevention of measles by vaccination.
Perkins FT
Trans R Soc Trop Med Hyg; 1975; 69(1):24-5. PubMed ID: 1145714
[No Abstract] [Full Text] [Related]
14. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
[TBL] [Abstract][Full Text] [Related]
15. Booster vaccination with further live attenuated measles vaccine.
Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
[TBL] [Abstract][Full Text] [Related]
16. Studies on the modification of the live AIK measles vaccine. I. Adaptation of the further attenuated AIK measles virus (the strain AIK-L33) to chick embryo cells.
Sasaki K
Kitasato Arch Exp Med; 1974 Jun; 47(1-2):1-12. PubMed ID: 4217404
[No Abstract] [Full Text] [Related]
17. [Comparative value of 3 anti-measles vaccines with attenuated live virus. Immuno-epidemiological study].
Topciu V; Arion R; Moldovan E; Csaky N; Olaru G
Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):119-27. PubMed ID: 5096857
[No Abstract] [Full Text] [Related]
18. [Measles immunization and its problems].
Kökkaya A
Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618
[TBL] [Abstract][Full Text] [Related]
19. [Live vaccines against influenza and measles].
Smorodintsev AA
Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):33-7. PubMed ID: 6485659
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.
Nakayama T; Urano T; Osano M; Nakagawa M; Maehara N; Sasaki K; Yamamura AM; Makino S
Microbiol Immunol; 1990; 34(6):497-508. PubMed ID: 2120551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
